Humacyte Reports More Positive Results from Engineered Blood Vessels in Ukraine By Barry Teater | September 5, 2024 Durham-based Humacyte has presented positive long-term results from its bioengineered blood vessels [….]
Weekly Quick Hits (Research Triangle Park) – Week of May 8, 2023 By Alex KeownMay 12, 2023 Funding, Awards and Collaborations Humacyte Secures $160 Million in Funding from Oberland Capital [….]
Weekly Quick Hits (Research Triangle Park) – Week of April 24, 2023 By Alex Keown, Mark Terry, and Sarah EllinwoodApril 28, 2023 Funding, Awards and Collaborations Tavros Therapeutics, OpenBench Expand [….]
Weekly Quick Hits (Research Triangle Park) – Week of April 17, 2023 By Alex Keown, Mark Terry, and Sarah EllinwoodApril 21, 2023 In the Clinic Renovion, Inc. Enrolls First Patient [….]
